Consistently, we found conditional Srsf3 KO in mouse mammary glands prevent c-neu (Erbb2) expression and thus, Erbb2 breast cancer induction, providing for the first time the direct in vivo evidence of Srsf3’s oncogenic feature. This evidence concerns the gene SRSF3 and breast carcinoma.